REFERENCES
- Baltimore, D., P. Berg, M. Botchan, et al. 2015. A prudent path forward for genomic engineering and germline gene modification. Science 348 (6230):36–38. doi:10.1126/science.aab1028.
- Collins, F. S. 2015. Statement on NIH funding of research using gene-editing technologies in human embryos (statement, April 4, 2015). National Institutes of Health. Available at https://www.nih.gov/about-nih/who-we-are/nih-director/statements/statement-nih-funding-research-using-gene-editing-technologies-human-embryos (accessed September 28, 2017)
- Dickert, N. W., N. Eyal, S. Goldkind, et al. 2017. Reframing consent for clinical research: A function-based approach. American Journal of Bioethics 17 (12):3–11.
- Evitt, N. H., S. Mascharak, and R. B. Altman. 2015. Human germline CRISPR-Cas modification: Toward a regulatory framework. American Journal of Bioethics 15 (12):25–29. doi:10.1080/15265161.2015.1104160.
- Gunderson, M. 2008. Genetic engineering and the consent of future persons. Journal of Evolution & Technology 18 (1):86–93.
- Gyngell, C., T. Douglas, and J. Savulescu. 2017. The ethics of germline gene editing. Journal of Applied Philosophy 34 (4):498–513. doi:10.1111/japp.12249.
- Habermas, J. 2003. The future of human nature. Cambridge, UK: Polity Press.
- Holm, S. 2002. The role of informed consent in genetic experimentation. In A companion to genethics, ed. J. Burleyand and J. Harris, 82–91. Malden, MA: Blackwell.
- Lanphier, E., F. Urnov, S. E. Haecker, M. Werner, and J. Smolenski. 2015. Don't edit the human germ line. Nature 519 (7544):410–11. doi:10.1038/519410a.
- National Academies of Sciences, Engineering, and Medicine. 2017. Human genome editing: Science, ethics, and governance. Washington, DC: National Academy of Sciences.
- Smolenski, J. 2015. CRISPR/Cas9 and germline modification: New difficulties in obtaining informed consent. American Journal of Bioethics 15 (12):35–37. doi:10.1080/15265161.2015.1103816.